A Study to Evaluate the Efficacy and Safety of KarXT + KarX-EC for Cognitive Impairment in Alzheimer's Disease (MINDSET 2)
for Alzheimer's Disease
26 locations incl. Fullerton
Sponsor: Bristol-Myers Squibb
Sex: All·Age: 60 - 85
Code: NCT06976203·Phase 3·Recruiting·Listed May 2025